[Studies on long-term intermittent immunochemotherapy of lung cancer--with special reference to surgical cases].
D000230:Adenocarcinoma / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery / Q000628:therapy*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*; D011379:Prognosis
D000970:Antineoplastic Agents; D001688:Biological Products; D010844:Picibanil